<qa>  What is the gene promoter in the tumor tissue?CORE is a Phase 2 clinical trial in newly diagnosed glioblastoma in subjects with an unmethylated O6-methylguanine-deoxyribonucleic acid methyltransferase MGMT gene promoter in the tumor tissue. 